← FDA Drug Approvals (Drugs@FDA)
SAPHRIS
NDA · New Drug Application · Sponsor: ABBVIE · Approved 2009-08-13
Drug application
- FDA Application #
NDA022117- Application type
- New Drug Application
- Brand name
- SAPHRIS
- Generic name
- ASENAPINE MALEATE
- Active ingredients
- ASENAPINE MALEATE
- Dosage form
- TABLET
- Route
- SUBLINGUAL
- Marketing status
- Prescription
- Sponsor
- ABBVIE
- Manufacturer
- Allergan, Inc.
- First approval
- 2009-08-13
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown